E Fund Management (HK)
IMVT icon

E Fund Management (HK)’s Immunovant IMVT Stock Holding History

E Fund Management (HK)’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17.3K Sell
511
-260
-34% -$10.2K ﹤0.01% 435
2026
Q2 		$29.7K Buy
771
+230
+43% +$7.01K 0.01% 238
2026
Q1 		$13.4K Buy
+541
New +$14K 0.01% 294

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

E Fund Management (HK)'s IMVT Position: Q3 2026 in Review

E Fund Management (HK) reduced its Immunovant (IMVT) stake by 34% in Q3 2026, selling an estimated $10.2K and leaving 511 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #435.

E Fund Management (HK) first reported a position in IMVT in Q1 2026 and has held it in 3 quarters since. The position peaked at $29.7K in Q2 2026. 103 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • E Fund Management (HK) held 511 shares of Immunovant worth $17.3K as of Q3 2026.
  • E Fund Management (HK) sold 260 Immunovant shares in Q3 2026, an estimated $10.2K.
  • Immunovant made up ﹤0.01% of E Fund Management (HK)'s portfolio in Q3 2026, its #435 holding.
  • E Fund Management (HK) first reported a position in Immunovant in Q1 2026 and has held it in 3 quarters since.
  • E Fund Management (HK)'s Immunovant position peaked at $29.7K in Q2 2026.
  • 103 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on E Fund Management (HK)'s 13F filing for Q3 2026, filed 12 Nov 2026.